Delivery Order SPE2DB20D2104-SPE2DB25FNBGN
Award Date 9/23/25
Potential Completion Date 9/24/25
Potential Value $9.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,372.73 to AmerisourceBergen Drug Corp on August 19, 2025, for RINVOQ ER 15 mg tablets (30-count units). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, demonstrating the contractor's ability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) valued at $17,437.44. This firm fixed-price delivery order, which is expected to be completed by September 10, 2025, represents a non-set-aside competitive procurement. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded a $26,705.50 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) with a firm fixed price structure. This non-competitive delivery order was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $33,129.47. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and carries no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $9,188.42 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed price contract utilizes no set-aside designation and represents a competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.70 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $41,153.31 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the opportunity was open to all...
- The Defense Logistics Agency awarded a $28,730.55 firm fixed price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $20,324.39 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit dose packages) on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract is being performed at the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for RINVOQ ER 30 mg tablets in a quantity of 30-unit packages, with a ceiling value of $9,335. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The order is scheduled for completion by August 28, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ...